Walleye Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
13,300
-6,400
-32% -$516K ﹤0.01% 2012
2026
Q1
$1.39M Sell
19,700
-12,300
-38% -$921K 0.01% 1776
2025
Q4
$2.53M Sell
32,000
-263,400
-89% -$20.8M 0.01% 1690
2025
Q3
$24.3M Sell
295,400
-14,000
-5% -$1.1M 0.09% 197
2025
Q2
$24.9M Buy
309,400
+8,500
+3% +$656K 0.1% 165
2025
Q1
$24.2M Sell
300,900
-129,500
-30% -$10.8M 0.11% 156
2024
Q4
$35.2M Sell
430,400
-18,000
-4% -$1.5M 0.09% 179
2024
Q3
$37M Sell
448,400
-58,600
-12% -$4.38M 0.08% 165
2024
Q2
$35.6M Sell
507,000
-72,400
-12% -$5.17M 0.06% 192
2024
Q1
$42.9M Sell
579,400
-173,800
-23% -$12.1M 0.08% 170
2023
Q4
$49.8M Buy
753,200
+190,000
+34% +$11.9M 0.11% 109
2023
Q3
$35.4M Sell
563,200
-18,800
-3% -$1.17M 0.09% 118
2023
Q2
$32.9M Buy
582,000
+574,400
+7,558% +$31.9M 0.12% 87
2023
Q1
$440K Buy
+7,600
New +$513K 0.01% 1823
2020
Q1
Sell
-16,600
Closed -$846K 1383
2019
Q4
$846K Buy
+16,600
New +$801K 0.05% 477

Other funds holding MET

Walleye Capital's MET Position: Q2 2026 in Review

Walleye Capital reduced its MetLife (MET) stake by 84% in Q2 2026, selling an estimated $645K and leaving 1,484 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.

Walleye Capital first reported a position in MET in Q4 2019 and has held it in 19 quarters since. The position peaked at $22.9M in Q3 2023. 1,448 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Walleye Capital held 1,484 shares of MetLife worth $126K as of Q2 2026.
  • Walleye Capital sold 7,992 MetLife shares in Q2 2026, an estimated $645K.
  • MetLife made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3757 holding.
  • Walleye Capital first reported a position in MetLife in Q4 2019 and has held it in 19 quarters since.
  • Walleye Capital's MetLife position peaked at $22.9M in Q3 2023.
  • 1,448 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.